China Pharma Holdings, Inc. (NYSE:CPHI) Q1 2019 Earnings Conference Call May 15, 2019 8:30 AM ET Company Participants Diana Huang - Investor Relations, Manager Zhilin Li - President and Chief Executive Officer and Interim Chief Financial Officer Sam Hsing - Corporate Vice President Conference Call Participants Operator Ladies and gentlemen, thank you standing by and welcome to China Pharma Holdings Inc. Q1 2019 Earnings Conference Call. At this time, all participants are in listen-only mode. There will be a ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from ____________ to ____________ Commission File Number 001-34471 CHINA PHARMA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada (Stateo ...

China Pharma Holdings, Inc. (NYSE:CPHI) Q4 2018 Results Conference Call March 29, 2019 8:00 AM ET Company Participants Diana Huang - IR, Manager Zhilin Li - President, CEO and Interim CFO Sam Hsing - Corporate Vice President Conference Call Participants Operator Thank you, ladies and gentlemen, and welcome to China Pharma Holdings Incorporated Full Year 2018 Earnings Conference Call. At this time, all participants are in listen-only mode. Presentation should be followed by question-and-answer session. I mus ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Common Stock, $0.001 Par Value Per Share NYSE American FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _____________ Commission file number: 001-34471 China Pharma Holdings, Inc. (Exact name of registrant as specified ...